Ticker Report Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) Chairman Neil Desai sold 40,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average...\n more…
Ticker Report Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the target of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 302,600...\n more…
Ticker Report Piper Sandler Companies lowered shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday morning, Stock...\n more…
Ticker Report Piper Sandler cut shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from an overweight rating to a neutral rating in a report published on Tuesday morning, Marketbeat.com reports. Piper Sandler...\n more…